Comparison of the dose-response relationships of 2 lipid-lowering agents: A Bayesian meta-analysis
- 30 June 2003
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 145 (6), 1036-1045
- https://doi.org/10.1016/s0002-8703(03)00106-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemiaThe American Journal of Cardiology, 2001
- Current Perspectives on StatinsCirculation, 2000
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Toward Evidence-Based Medical Statistics. 1: The P Value FallacyAnnals of Internal Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 1995